Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million
12/11/2025 23:07
Nov 12 (Reuters) - Medexus Pharmaceuticals Q2 adjusted EBITDA USD 4.351 million. Q2 net income USD -315 thousand
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million